Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Reduced EF Evident in Some Elite Endurance Athletes

Michael O'Riordan

December 21, 2023

News Daily News

Who Benefits Most From Semaglutide and How Long Will That Take?

Shelley Wood

December 19, 2023

News Daily News

Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data

Yael L. Maxwell

December 13, 2023

News Daily News

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

L.A. McKeown

December 08, 2023

News Conference News AHA 2023

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

L.A. McKeown

November 17, 2023

News Conference News AHA 2023

AI Improves Detection of Cardiomyopathy in Pregnancy

L.A. McKeown

November 15, 2023

News Conference News AHA 2023

POP-HT: Physician-Guided Self-Monitoring Improves BP After Hypertensive Pregnancy

L.A. McKeown

November 13, 2023

News Conference News HFSA 2023

PA Pressure Monitoring Benefits HF Patients With No Recent Hospitalization

L.A. McKeown

October 12, 2023

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

Todd Neale

October 11, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2023

Caitlin E. Cox

September 04, 2023

News Conference News ESC 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

L.A. McKeown

September 01, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

Shelley Wood

August 25, 2023

News Opinion Editor's Corner ESC 2023

What’s Going to Be Hot at ESC 2023?

Shelley Wood

August 15, 2023

News Daily News

Study Finds No Increased Risk of CVD Years After Infertility Therapies

L.A. McKeown

August 11, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Conference News ESC Heart Failure 2023

SGLT2i Still Underprescribed in HFrEF, New US Analysis Confirms

L.A. McKeown

June 06, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Features THT 2023

The Promise of AI for Improving Health Equity in Heart Failure

Todd Neale

April 04, 2023

Advertisement

AHA Selects 2023’s Leading Cardiovascular Research

Reduced EF Evident in Some Elite Endurance Athletes

Who Benefits Most From Semaglutide and How Long Will That Take?

Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

AI Improves Detection of Cardiomyopathy in Pregnancy

POP-HT: Physician-Guided Self-Monitoring Improves BP After Hypertensive Pregnancy

PA Pressure Monitoring Benefits HF Patients With No Recent Hospitalization

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

TCTMD’s Top 10 Most Popular Stories for August 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

What’s Going to Be Hot at ESC 2023?

Study Finds No Increased Risk of CVD Years After Infertility Therapies

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

SGLT2i Still Underprescribed in HFrEF, New US Analysis Confirms

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

The Promise of AI for Improving Health Equity in Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content